OTLK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Outlook Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.42 USD 2.9% Market Closed

Market Cap: $227.4m

	Outlook Therapeutics Inc NASDAQ:OTLK	US
Q	Qiagen NV F:QIA	NL
	GoGold Resources Inc TSX:GGD	CA
	Anheuser Busch Inbev SA F:1NBA	BE
C	Country Garden Services Holdings Co Ltd OTC:CTRGF	CN
	Jensen-Group NV XBRU:JEN	BE
C	Crown Castle International Corp F:8CW	US

Profitability Summary

Outlook Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-58%

Low 3Y Average Gross Margin

Negative Operating Margin

-19.811%

Negative 3Y Average Operating Margin

-9.793%

Negative Net Margin

-34.575%

Negative 3Y Average Net Margin

-13.959%

Negative Free Cash Flow Margin

-18.757%

Negative 3Y Average Free Cash Flow Margin

-8.720%

Exceptional ROE

232%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1.960%

Declining ROIC

-693% > -8.711%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.